The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
Abstract
Parkinson's disease (PD) is a common progressive neurodegenerative disorder caused by the loss of dopaminergic neurons in the substantia nigra. Although mutations in alpha-synuclein have been identified in autosomal dominant PD, the mechanism by which dopaminergic neural cell death occurs remains unknown. Proteins encoded by two other genes in which mutations cause familial PD, parkin and UCH-L1, are involved in regulation of the ubiquitin-proteasome pathway, suggesting that dysregulation of the ubiquitin-proteasome pathway is involved in the mechanism by which these mutations cause PD. We established inducible PC12 cell lines in which wild-type or mutant alpha-synuclein can be de-repressed by removing doxycycline. Differentiated PC12 cell lines expressing mutant alpha-synuclein showed decreased activity of proteasomes without direct toxicity. Cells expressing mutant alpha-synuclein showed increased sensitivity to apoptotic cell death when treated with sub-toxic concentrations of an exogenous proteasome inhibitor. Apoptosis was accompanied by mitochondrial depolarization and elevation of caspase-3 and -9, and was blocked by cyclosporin A. These data suggest that expression of mutant alpha-synuclein results in sensitivity to impairment of proteasome activity, leading to mitochondrial abnormalities and neuronal cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · cited 1×
“Caspase-9 is an upstream activator of caspase-3, and activation of caspase-9 is involved in mitochondrial-dependent apoptosis ( 46 ,47).”
BackgroundNagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., & Nagata, S. (1998) · Nature · doi:10.1038/34112 · Cited by 3,189
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“Proteins encloded by other causal genes of familial PD, parkin and UCH-L1, are a ubiquitin-protein ligase and a deubiquitinating enzyme, respectively (16,19).”
BackgroundTHE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS
Kroemer, G., Dallaporta, B., & Resche-Rigon, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.619 · Cited by 1,963
Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884 · cited 1×
“We monitored the green:red ratio using confocal microscopy and analyzed as described (33,65).”
MethodLiu, X., Zou, H., Slaughter, C., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80197-x · Cited by 1,834
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9
Kuida, K., Haydar, T. F., Kuan, C.-Y., Gu, Y., Taya, C., Karasuyama, H., Su, M. S.-S., Rakic, P., & Flavell, R. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81476-2 · Cited by 1,643
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
An Induced Proximity Model for Caspase-8 Activation
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Mitochondrial permeability transition is a central coordinating event of apoptosis.
Marchetti, P., Castedo, M., Susin, S. A., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., & Kroemer, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1155 · Cited by 847
Imai, Y., Soda, M., & Takahashi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000447200 · Cited by 766
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714
Proteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Schindzielorz, A., Okochi, M., Leimer, U., van der Putten, H., Probst, A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06365.2000 · Cited by 641
α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., & Wolozin, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05782.1999 · Cited by 564
Sawa, A., Wiegand, G. W., Cooper, J., Margolis, R. L., Sharp, A. H., Lawler, J. F., Greenamyre, J. T., Snyder, S. H., & Ross, C. A. (1999) · Nature Medicine · doi:10.1038/13518 · Cited by 552
Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds
Tipton, K. F., & Singer, T. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13610.x · Cited by 539
Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Dunnett, S. B., & Björklund, A. (1999) · Nature · doi:10.1038/399a032 · Cited by 537
Neuropathology in mice expressing human alpha-synuclein
van der Putten, H., Wiederhold, K., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P. J. M., Rüegg, M. A., et al. (2000) · PubMed · doi:10.5451/unibas-ep2767 · Cited by 505
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
Saigoh, K., Wang, Y.-L., Suh, J.-G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T., et al. (1999) · Nature Genetics · doi:10.1038/12647 · Cited by 502
Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M., & Bernardi, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2185 · Cited by 479
Tatton, N. A., & Kish, S. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00545-3 · Cited by 468
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Histochemical detection of apoptosis in Parkinson's disease
Mochizuki, H., Goto, K., Mori, H., & Mizuno, Y. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00336-z · Cited by 452
Autoproteolytic Activation of Pro-Caspases by Oligomerization
Yang, X., Chang, H. Y., & Baltimore, D. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80032-5 · Cited by 434
Lactacystin, Proteasome Function, and Cell Fate
Fenteany, G., & Schreiber, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8545 · Cited by 410
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Zhang, Y., Dawson, V. L., & Dawson, T. M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0319 · Cited by 407
Substrate Specificity of Deubiquitinating Enzymes: Ubiquitin C-Terminal Hydrolases
Larsen, C. N., Krantz, B. A., & Wilkinson, K. D. (1998) · Biochemistry · doi:10.1021/bi972274d · Cited by 391
Genetic Classification of Primary Neurodegenerative Disease
Hardy, J., & Gwinn-Hardy, K. (1998) · Science · doi:10.1126/science.282.5391.1075 · Cited by 343
Tompkins, M. M., Basgall, E. J., ZAMRINI, E. Y., & Hill, W. D. (1997) · Europe PMC (PubMed Central) · Cited by 314
Offen, D., Ziv, I., Sternin, H., Melamed, E., & Hochman, A. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0136 · Cited by 250
Mitochondria in the etiology and pathogenesis of parkinson's disease
Schapira, A. H. V., Gu, M., Taanman, J. ‐., Tabrizi, S. J., Seaton, T., Cleeter, M., & Cooper, J. M. (1998) · Annals of Neurology · doi:10.1002/ana.410440714 · Cited by 238
Ii, K., ITO, H., TANAKA, K., & HIRANO, A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00002 · Cited by 215
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity
Tabrizi, S. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2683 · Cited by 197
Chang, Y., Lee, Y. S., Tejima, T., Tanaka, K., Ōmura, S., Heintz, N. H., Mitsui, Y., & Magae, J. (1998) · PubMed · Cited by 180
Mitochondrial dysfunction in parkinson's disease
Mizuno, Y., Yoshino, H., Ikebe, S., Hattori, N., Kobayashi, T., Shimoda‐Matsubayashi, S., Matsumine, H., & Kondo, T. (1998) · Annals of Neurology · doi:10.1002/ana.410440715 · Cited by 164
Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family
Swerdlow, R. H., Parks, J. K., Davis, J. N., Cassarino, D. S., Trimmer, P. A., Currie, L. J., Dougherty, J., Bridges, W. S., Bennett, J. P., Wooten, G. F., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440605 · Cited by 148
Interaction of Alzheimer's Presenilin-1 and Presenilin-2 with Bcl-XL
Passer, B. J., Pellegrini, L., Vito, P., Ganjei, J. K., & D'adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24007 · Cited by 107
Dopamine induces proteasome inhibition in neural PC12 cell line
Keller, J. N., Huang, F. F., Dimayuga, E. R., & Maragos, W. F. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00412-3 · Cited by 99
Cassarino, D. S., Swerdlow, R. H., Parks, J. K., Parker, W. D., & Bennett, J. P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8866 · Cited by 98
Rat α‐Synuclein Interacts with Tat Binding Protein 1, a Component of the 26S Proteasomal Complex
Ghee, M., Fournier, A., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752221.x · Cited by 96
Superoxide mediates the cell-death-enhancing action of presenilin-1 mutations
Guo, Q., Fu, W., Holtsberg, F. W., Steiner, S. M., & Mattson, M. P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990601)56:5<457::aid-jnr2>3.0.co;2-p · Cited by 74
Mitochondrial Dysfunction in Neurodegeneration
Cooper, J. A. D., & Schapira, A. H. V. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022642114734 · Cited by 68
Ziv, I., Barzilai, A., Offen, D., Nardi, N., & Melamed, E. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_7 · Cited by 31
Cited by
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
“Aberrant a-synuclein, mutant, or under certain circumstances, WT, can induce proteasomal dysfunction in a number of cell-free, cellular, and in vivo settings (Stefanis et al. 2001; Tanaka et al. 2001; Petrucelli et al. 2002; Snyder et al. 2003), although this is not universally observed (Martin-Clemente et al.”
BackgroundMOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Metadata
- Authors
- Tanaka, Y.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-04-01
- Volume
- 10
- Issue
- 9
- Pages
- 919-926
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2104912043
- Cited by
- 497
- References
- 62
- FWCI
- 25.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.